Why These Three, and Why Now
Key Takeaways Key Takeaways Plentum wins this head-to-head on evidence (two peer-reviewed canine trials), transparency (full label disclosure of every ingredient and dose), and oral-health coverage — a category Zesty Paws and PetLab Co do not address. Zesty Paws underperforms on evidence (no product-level canine RCTs) and carries PE-ownership opacity following BC Partners’ reported $610…